The U.S. Food and Drug Administration (FDA) granted breakthrough device designation to the CorVista System, a point-of-care diagnostic tool that…
Articles by Marisa Wexler, MS
Switching from weekly infusions of levosimendan to a daily oral version of the experimental medication was well-tolerated among people with…
Treatment with sotatercept, given in addition to standard therapies, significantly improves exercise capacity in people with pulmonary arterial hypertension…
Two weeks of aerobic exercise improved blood flow parameters and survival in a rat model of pulmonary arterial hypertension…
A high dose of Tyvaso (inhaled treprostinil) — at least nine breaths four times per day — is more…
The U.S. Food and Drug Administration (FDA) has accepted a proposal from Bellerophon Therapeutics to reduce the size of a…
Treatment with Pulnovo Medical‘s pulmonary artery denervation (PADN) device improved exercise capacity, blood flow dynamics, and clinical outcomes for…
Mice that lack a protein called AMPK in the muscle around their blood vessels develop a lethal disease that appears…
Scores on standardized risk assessments showed a clear treatment effect with Orenitram (treprostinil) after three months in a…
The European Society of Cardiology (ESC) and the European Respiratory Society (ERS) have published a new set of guidelines for…
More than half of babies born preterm at a center in the Netherlands were found to have pulmonary hypertension…
Treatment with Adempas (riociguat) improved blood flow measurements in people with pulmonary hypertension and heart failure with preserved…